keyword
https://read.qxmd.com/read/38621561/development-of-a-novel-monoclonal-antibody-based-competitive-elisa-for-antibody-detection-against-bovine-leukemia-virus
#1
JOURNAL ARTICLE
Jing Wang, Chao Sun, Zhe Hu, Fang Wang, Jitao Chang, Ming Gao, Dandan Ye, Qi Jia, Hui Zou, Luc Willems, Zhigang Jiang, Xin Yin
Infection with bovine leukemia virus (BLV) leads to enzootic bovine leukosis, the most prevalent neoplastic disease in cattle. Due to the lack of commercially available vaccines, reliable eradication of the disease can be achieved through the testing and elimination of BLV antibody-positive animals. In this study, we developed a novel competitive ELISA (cELISA) to detect antibodies against BLV capsid protein p24. Recombinant p24 protein expressed by Escherichia coli, in combination with the monoclonal antibody 2G11 exhibiting exceptional performance, was used for the establishment of the cELISA...
April 13, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38618935/aav-mediated-gene-therapies-for-glaucoma-and-uveitis-are-we-there-yet
#2
REVIEW
Brenda Castro, Jason C Steel, Christopher J Layton
Glaucoma and uveitis are non-vascular ocular diseases which are among the leading causes of blindness and visual loss. These conditions have distinct characteristics and mechanisms but share a multifactorial and complex nature, making their management challenging and burdensome for patients and clinicians. Furthermore, the lack of symptoms in the early stages of glaucoma and the diverse aetiology of uveitis hinder timely and accurate diagnoses, which are a cause of poor visual outcomes under both conditions...
April 15, 2024: Expert Reviews in Molecular Medicine
https://read.qxmd.com/read/38617325/mechanism-of-enterovirus-vp0-maturation-cleavage-based-on-the-structure-of-a-stabilised-assembly-intermediate
#3
Natalie J Kingston, Joseph S Snowden, Keith Grehan, Philippa K Hall, Eero V Hietanen, Tim C Passchier, Stephen J Polyak, David J Filman, James M Hogle, David J Rowlands, Nicola J Stonehouse
Molecular details of genome packaging are little understood for the majority of viruses. In enteroviruses (EVs), cleavage of the structural protein VP0 into VP4 and VP2 is initiated by the incorporation of RNA into the assembling virion and is essential for infectivity. We have applied a combination of bioinformatic, molecular and structural approaches to generate the first high-resolution structure of an intermediate in the assembly pathway, termed a provirion, which contains RNA and intact VP0. We have demonstrated an essential role of VP0 E096 in VP0 cleavage independent of RNA encapsidation and generated a new model of capsid maturation, supported by bioinformatic analysis...
April 6, 2024: bioRxiv
https://read.qxmd.com/read/38614100/rna-genome-packaging-and-capsid-assembly-of-bluetongue-virus-visualized-in-host-cells
#4
JOURNAL ARTICLE
Xian Xia, Po-Yu Sung, Michael W Martynowycz, Tamir Gonen, Polly Roy, Z Hong Zhou
Unlike those of double-stranded DNA (dsDNA), single-stranded DNA (ssDNA), and ssRNA viruses, the mechanism of genome packaging of dsRNA viruses is poorly understood. Here, we combined the techniques of high-resolution cryoelectron microscopy (cryo-EM), cellular cryoelectron tomography (cryo-ET), and structure-guided mutagenesis to investigate genome packaging and capsid assembly of bluetongue virus (BTV), a member of the Reoviridae family of dsRNA viruses. A total of eleven assembly states of BTV capsid were captured, with resolutions up to 2...
April 5, 2024: Cell
https://read.qxmd.com/read/38614087/cryo-em-structure-of-flagellotropic-bacteriophage-chi
#5
JOURNAL ARTICLE
Ravi R Sonani, Nathaniel C Esteves, Birgit E Scharf, Edward H Egelman
The flagellotropic bacteriophage χ (Chi) infects bacteria via the flagellar filament. Despite years of study, its structural architecture remains partly characterized. Through cryo-EM, we unveil χ's nearly complete structure, encompassing capsid, neck, tail, and tail tip. While the capsid and tail resemble phage YSD1, the neck and tail tip reveal new proteins and their arrangement. The neck shows a unique conformation of the tail tube protein, forming a socket-like structure for attachment to the neck...
April 3, 2024: Structure
https://read.qxmd.com/read/38612545/design-and-synthesis-of-new-gs-6207-subtypes-for-targeting-hiv-1-capsid-protein
#6
JOURNAL ARTICLE
Thamina Akther, William M McFadden, Huanchun Zhang, Karen A Kirby, Stefan G Sarafianos, Zhengqiang Wang
HIV-1 capsid protein (CA) is the molecular target of the recently FDA-approved long acting injectable (LAI) drug lenacapavir (GS-6207). The quick emergence of CA mutations resistant to GS-6207 necessitates the design and synthesis of novel sub-chemotypes. We have conducted the structure-based design of two new sub-chemotypes combining the scaffold of GS-6207 and the N-terminal cap of PF74 analogs, the other important CA-targeting chemotype. The design was validated via induced-fit molecular docking. More importantly, we have worked out a general synthetic route to allow the modular synthesis of novel GS-6207 subtypes...
March 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612429/molecular-evolution-of-gii-p31-gii-4_sydney_2012-norovirus-over-a-decade-in-a-clinic-in-japan
#7
JOURNAL ARTICLE
Hiroshi Ushijima, Sheikh Ariful Hoque, Yuki Akari, Ngan Thi Kim Pham, Tung Phan, Shuichi Nishimura, Masaaki Kobayashi, Kumiko Sugita, Shoko Okitsu, Satoshi Komoto, Aksara Thongprachum, Pattara Khamrin, Niwat Maneekarn, Satoshi Hayakawa
Norovirus (NoV) genogroup II, polymerase type P31, capsid genotype 4, Sydney_2012 variant (GII.P31/GII.4_Sydney_2012) has been circulating at high levels for over a decade, raising the question of whether this strain is undergoing molecular alterations without demonstrating a substantial phylogenetic difference. Here, we applied next-generation sequencing to learn more about the genetic diversity of 14 GII.P31/GII.4_Sydney_2012 strains that caused epidemics in a specific region of Japan, with 12 from Kyoto and 2 from Shizuoka, between 2012 and 2022, with an emphasis on amino acid (aa) differences in all three ORFs...
March 23, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611099/the-micro-immunotherapy-medicine-2lpapi-%C3%A2-displays-immune-modulatory-effects-in-a-model-of-human-papillomavirus-type-16-l1-protein-capsid-treated-human-peripheral-blood-mononuclear-cells-and-antiproliferative-effects-in-a-model-of-cervical-cancer-cells
#8
JOURNAL ARTICLE
Camille Jacques, Flora Marchand, Mathias Chatelais, Virginie Albinet, Claire Coustal, Ilaria Floris
Human papillomavirus (HPV) is the second most common infectious agent causing cancer. Persistent infection with high-risk (HR)-HPV can lead to cervical intra-epithelial neoplasia and cervical carcinomas (CC). While host immune response is necessary for viral clearance, chronic immune activation contributes to a low-grade inflammation that can ultimately lead to carcinogenesis. The micro-immunotherapy medicine (MIM) 2LPAPI® could be a valuable tool to manage the clearance of the virus and reduce the risk of developing CC...
April 5, 2024: Cancers
https://read.qxmd.com/read/38608492/strong-evolutionary-constraints-against-amino-acid-changes-in-the-p2-subdomain-of-sapovirus-gi-1-capsid-protein-vp1
#9
JOURNAL ARTICLE
Masaru Yokoyama, Yen Hai Doan, Kazushi Motomura, Hironori Sato, Tomoichiro Oka
Sapovirus (SaV) is a nonenveloped RNA virus that causes acute gastroenteritis in humans. Although SaV is a clinically important pathogen in children, an effective vaccine is currently unavailable. The capsid protein VP1 of SaVs forms the outer shell of the virion and is highly diverse, as often seen in the virion-surface proteins of RNA viruses, creating an obstacle for vaccine development. We here report a unique phenomenon pertaining to the variation of SaV VP1. Phylogenetic and information entropy analyses using full-length VP1 sequences from a public database consistently showed that the amino acid sequences of the VP1 protein have been highly conserved over more than 40 years in the major epidemic genotype GI...
April 2, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38606951/hepatitis-after-gene-therapy-what-are-the-possible-causes
#10
REVIEW
Ann Maina, Graham R Foster
Hepatitis is a common adverse event following gene therapy for haemophilia, often associated with a loss of transgene expression. Investigating the potential causes and implications of this is crucial for the overall success of treatment. Gene therapy trials using adeno-associated virus (AAV) vectors have demonstrated promising results marked by increases in factor FVIII and FIX levels and reductions in episodes of bleeding. However, hepatocellular injury characterised by elevations in alanine aminotransferases (ALT) has been noted...
April 2024: Journal of Viral Hepatitis
https://read.qxmd.com/read/38605812/development-of-adenoviral-vectors-that-transduce-purkinje-cells-and-other-cerebellar-cell-types-in-the-cerebellum-of-a-humanized-mouse-model
#11
JOURNAL ARTICLE
Emre Kul, Uchechi Okoroafor, Amanda Dougherty, Lauren Palkovic, Hao Li, Paula Valiño-Ramos, Leah Aberman, Samuel M Young
Viral vector gene therapy has immense promise for treating central nervous system (CNS) disorders. Although adeno-associated virus vectors (AAVs) have had success, their small packaging capacity limits their utility to treat the root cause of many CNS disorders. Adenoviral vectors (Ad) have tremendous potential for CNS gene therapy approaches. Currently, the most common vectors utilize the Group C Ad5 serotype capsid proteins, which rely on the Coxsackievirus-Adenovirus receptor (CAR) to infect cells. However, these Ad5 vectors are unable to transduce many neuronal cell types that are dysfunctional in many CNS disorders...
June 13, 2024: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38604120/crafty-mimicry-grants-nuclear-pore-entry-to-hiv
#12
JOURNAL ARTICLE
Keesiang Lim, Masaharu Hazawa, Richard W Wong
The size of the nuclear pore should, in principle, prevent HIV-1 entry. However, HIV-1 capsid is able to gain nuclear pore entry. In a recent issue of Nature, Fu et al. and Dickson et al. demonstrate that the HIV-1 capsid mimics the nuclear transport protein karyopherins to access host nuclei.
April 10, 2024: Cell Host & Microbe
https://read.qxmd.com/read/38599392/global-distribution-cross-species-transmission-and-receptor-binding-of-canine-parvovirus-2-risks-and-implications-for-humans
#13
JOURNAL ARTICLE
Songbiao Chen, Ke Shang, Jian Chen, Zuhua Yu, Ying Wei, Lei He, Ke Ding
For canine parvovirus type 2 (CPV-2), a zoonotic virus capable of cross-species transmission in animals, the amino acid changes of capsid protein VP2 are key factors when binding to other species' transferrin receptors (TfR). CPV-2 variants can spread from felines and canines, for example, to Carnivora, Artiodactyla, and Pholidota species, and CPV-2c variants are essential to spread from Carnivora to Artiodactyla and Pholidota species in particular. In our study, a CPV-2a variant maintained a relatively stable trend, and the proportion of CPV-2c gradually rose from 1980 to 2021...
April 8, 2024: Science of the Total Environment
https://read.qxmd.com/read/38598627/structure-and-replication-cycle-of-a-virus-infecting-climate-modulating-alga-emiliania-huxleyi
#14
JOURNAL ARTICLE
Miroslav Homola, Carina R Büttner, Tibor Füzik, Pavel Křepelka, Radka Holbová, Jiří Nováček, Marten L Chaillet, Jakub Žák, Danyil Grybchuk, Friedrich Förster, William H Wilson, Declan C Schroeder, Pavel Plevka
The globally distributed marine alga Emiliania huxleyi has cooling effect on the Earth's climate. The population density of E. huxleyi is restricted by Nucleocytoviricota viruses, including E. huxleyi virus 201 (EhV-201). Despite the impact of E. huxleyi viruses on the climate, there is limited information about their structure and replication. Here, we show that the dsDNA genome inside the EhV-201 virion is protected by an inner membrane, capsid, and outer membrane. EhV-201 virions infect E. huxleyi by using fivefold vertices to bind to and fuse the virus' inner membrane with the cell plasma membrane...
April 12, 2024: Science Advances
https://read.qxmd.com/read/38598600/high-resolution-comparative-atomic-structures-of-two-giardiavirus-prototypes-infecting-g-duodenalis-parasite
#15
JOURNAL ARTICLE
Han Wang, Gianluca Marucci, Anna Munke, Mohammad Maruf Hassan, Marco Lalle, Kenta Okamoto
The Giardia lamblia virus (GLV) is a non-enveloped icosahedral dsRNA and endosymbiont virus that infects the zoonotic protozoan parasite Giardia duodenalis (syn. G. lamblia, G. intestinalis), which is a pathogen of mammals, including humans. Elucidating the transmission mechanism of GLV is crucial for gaining an in-depth understanding of the virulence of the virus in G. duodenalis. GLV belongs to the family Totiviridae, which infects yeast and protozoa intracellularly; however, it also transmits extracellularly, similar to the phylogenetically, distantly related toti-like viruses that infect multicellular hosts...
April 10, 2024: PLoS Pathogens
https://read.qxmd.com/read/38593321/structural-analyses-of-the-gi-4-norovirus-by-cryo-electron-microscopy-and-x-ray-crystallography-revealing-binding-sites-for-human-monoclonal-antibodies
#16
JOURNAL ARTICLE
Tomomi Kimura-Someya, Kazushige Katsura, Miyuki Kato-Murayama, Toshiaki Hosaka, Tomomi Uchikubo-Kamo, Kentaro Ihara, Kazuharu Hanada, Shin Sato, Kazutaka Murayama, Michiyo Kataoka, Mikako Shirouzu, Yuichi Someya
UNLABELLED: Noroviruses are major causative agents of acute nonbacterial gastroenteritis in humans. There are neither antiviral therapeutic agents nor vaccines for noroviruses at this time. To evaluate the potential usefulness of two previously isolated human monoclonal antibody fragments, CV-1A1 and CV-2F5, we first conducted a single-particle analysis to determine the cryo-electron microscopy structure of virus-like particles (VLPs) from the genogroup I genotype 4 (GI.4) Chiba strain uniformly coated with CV-1A1 fragments...
April 9, 2024: Journal of Virology
https://read.qxmd.com/read/38592735/spectroscopic-analysis-of-the-bacterially-expressed-head-domain-of-rotavirus-vp6
#17
JOURNAL ARTICLE
Milaan Simone Strachan, Tshepo Mashapa, Samantha Gildenhuys
The rotavirus capsid protein VP6 forms the middle of three protein layers and is responsible for many critical steps in the viral life cycle. VP6 as a structural protein can be used in various applications including as a subunit vaccine component. The head domain of VP6 (VP6H) contains key sequences that allow the protein to trimerize and that represent epitopes that are recognized by human antibodies in the viral particle. The domain is rich in beta-sheet secondary structures. Here VP6H was solubilised from bacterial inclusion bodies and purified using a single affinity chromatography step...
April 9, 2024: Bioscience Reports
https://read.qxmd.com/read/38591900/vp2-mediates-the-release-of-the-feline-calicivirus-rna-genome-by-puncturing-the-endosome-membrane-of-infected-cells
#18
JOURNAL ARTICLE
Weiyao Sun, Ming Wang, Zhibin Shi, Pengfei Wang, Jinhui Wang, Bingchen Du, Shida Wang, Zhenzhao Sun, Zaisi Liu, Lili Wei, Decheng Yang, Xijun He, Jingfei Wang
Feline calicivirus (FCV) is one of the few members of the Caliciviridae family that grows well in cell lines and, therefore, serves as a surrogate to study the biology of other viruses in the family. Conley et al. (14) demonstrated that upon the receptor engagement to the capsid, FCV VP2 forms a portal-like assembly, which might provide a channel for RNA release. However, the process of calicivirus RNA release is not yet fully understood. Our findings suggest that the separation of the FCV capsid from its genome RNA (gRNA) occurs rapidly in the early endosomes of infected cells...
April 9, 2024: Journal of Virology
https://read.qxmd.com/read/38590916/degenprime-provides-robust-primer-design-and-optimization-unlocking-the-biosphere
#19
JOURNAL ARTICLE
Bryan Fulghum, Sophie H Tanker, Richard Allen White
MOTIVATION: Polymerase chain reaction (PCR) is the world's most important molecular diagnostic with applications ranging from medicine to ecology. PCR can fail because of poor primer design. The nearest-neighbor thermodynamic properties, picking conserved regions, and filtration via penalty of oligonucleotides form the basis for good primer design. RESULTS: DeGenPrime is a console-based high-quality PCR primer design tool that can utilize MSA formats and degenerate bases expanding the target range for a single primer set...
2024: Bioinform Adv
https://read.qxmd.com/read/38585985/unlocking-precision-gene-therapy-harnessing-aav-tropism-with-nanobody-swapping-at-capsid-hotspots
#20
Mareike D Hoffmann, Joseph P Gallant, Aaron M LeBeau, Daniel Schmidt
Adeno-associated virus has been remarkably successful in the clinic, but its broad tropism is a practical limitation of precision gene therapy. A promising path to engineer AAV tropism is the addition of binding domains to the AAV capsid that recognize cell surface markers present on a targeted cell type. We have recently identified two previously unexplored capsid regions near the 2-fold valley and 5-fold pore of the AAV capsid that are amenable to insertion of larger protein domains including nanobodies. Here, we demonstrate that these hotspots facilitate AAV tropism switching through simple nanobody replacement without extensive optimization in both VP1 and VP2...
March 27, 2024: bioRxiv
keyword
keyword
109276
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.